Laverock Therapeutics
About:
Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.
Website: https://www.laverocktx.com/
Top Investors: Eli Lilly, Innovate UK, Eos, Maven Capital Partners, Mercia Ventures
Description:
Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.
Total Funding Amount:
14.5M GBP
Headquarters Location:
Stevenage, Herefordshire, United Kingdom
Founded Date:
2022-02-01
Contact Email:
contact(AT)laverocktx.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2023-10-30
IPO Status:
Private
Industries:
© 2025 bioDAO.ai